Skip to main content

Versant Diagnostics Strengthens Chicago-Area Presence with New Acquisitions

These are Versant Diagnostics' third and fourth acquisitions in the past nine months

Versant Diagnostics, an independent physician services company, today announced the acquisitions of Pathology Consultants of Chicago located at 2525 South Michigan Avenue in Chicago and the ongoing assets and operations of Elgin Laboratory Physicians, Ltd. These practices increase the footprint and presence of Versant Diagnostics in the greater-Chicago market, and create a wider network of subspecialists for providers and patients.

“The acquisition of these prominent practices is the essence of our strategy and enables us to further support the community,” said Jim Billington, CEO of Versant Diagnostics. “We are proud to provide pathology groups with the resources needed for them to innovate and thrive in an exciting environment.”

Earlier this year, Versant Diagnostics announced its strategy to help facilitate access, accuracy and care to medical providers. Supported by more than $100 million in growth capital, the company will purchase pathology groups, while maintaining physician leadership and the integrity of each acquired practice. Further, the company will infuse capital into its practices to convert them to digital pathology.

“We are excited about these acquisitions and will be adding practices across the U.S. to Versant Diagnostics in the near future,” added Rob Albert, Chief Development Officer of Versant Diagnostics. “Our goal is to be the leading catalyst in improving medical diagnostics and patient outcomes through the convergence of the latest technology and leading physicians.”

In October 2021, Versant Diagnostics acquired Alliance Pathology Consultants and Addison Central Pathology, both located in the greater-Chicago market. The growing network and increasing investments are bringing pathology into the 21st Century with digital solutions designed to improve the precision, accuracy, and speed of pathology.

About Versant Diagnostics

Founded in 2021 by a leading physician and operating executives Ven Aduana, M.D., Jim Billington and Brian Carr, Versant Diagnostics is focused on anatomic pathology, precision medicine and the digital transformation of the industry. By combining technological advancements in healthcare with the most skilled and diverse set of subspecialty pathologists, Versant Diagnostics provides superior service for hospitals and physician practices. Learn more at www.versantdx.com.

“The acquisition of these prominent practices is the essence of our strategy and enables us to further support the community. We are proud to provide pathology groups with the resources needed for them to innovate and thrive in an exciting environment."

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.